Valentina Portalupi

Bergamo, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous Nephropathy.

Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous Nephropathy.

Journal: Kidney international reports
Published: October 14, 2025

Beyond Oral Anticoagulants Two Case Reports of Biopsy-Proven Heparin-Induced Anticoagulant-Related Nephropathy.

Beyond Oral Anticoagulants Two Case Reports of Biopsy-Proven Heparin-Induced Anticoagulant-Related Nephropathy.

Journal: Nephron
Published: October 13, 2025

Prospective Cohort Study of Obinutuzumab in Rituximab-Resistant Primary Membranous Nephropathy.

Prospective Cohort Study of Obinutuzumab in Rituximab-Resistant Primary Membranous Nephropathy.

Journal: Kidney international reports
Published: September 26, 2025

Cutaneous Alternariosis Caused by Alternaria infectoria: A Case Report in Kidney Transplant Recipient and Literature Review.

Cutaneous Alternariosis Caused by Alternaria infectoria: A Case Report in Kidney Transplant Recipient and Literature Review.

Journal: Journal of fungi (Basel, Switzerland)
Published: September 11, 2025

Case Report: Extracorporeal photopheresis for BK virus nephropathy as a novel treatment for high-risk rejection kidney transplant recipient.

Case Report: Extracorporeal photopheresis for BK virus nephropathy as a novel treatment for high-risk rejection kidney transplant recipient.

Journal: Frontiers in nephrology
Published: May 08, 2025

Engineered ATP-Loaded Extracellular Vesicles Derived from Mesenchymal Stromal Cells: A Novel Strategy to Counteract Cell ATP Depletion in an In Vitro Model.

Engineered ATP-Loaded Extracellular Vesicles Derived from Mesenchymal Stromal Cells: A Novel Strategy to Counteract Cell ATP Depletion in an In Vitro Model.

Journal: International journal of molecular sciences
Published: March 03, 2025

Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series.

Ofatumumab in Rituximab-Resistant and Rituximab-Intolerant Patients With Primary Membranous Nephropathy: A Case Series.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: April 18, 2023

Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study.

Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study.

Journal: PloS one
Published: June 11, 2021

C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19.

C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19.

Journal: Blood advances
Published: May 11, 2021

A view from the front line of the COVID-19 war.

A view from the front line of the COVID-19 war.

Journal: Kidney international
Published: April 18, 2020

Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration.

Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration.

Journal: Stem cells translational medicine
Published: June 26, 2019

Accelerating the Depletion of Circulating Anti-Phospholipase A2 Receptor Antibodies in Patients with Severe Membranous Nephropathy: Preliminary Findings with Double Filtration Plasmapheresis and Ofatumumab.

Accelerating the Depletion of Circulating Anti-Phospholipase A2 Receptor Antibodies in Patients with Severe Membranous Nephropathy: Preliminary Findings with Double Filtration Plasmapheresis and Ofatumumab.

Journal: Nephron
Published: April 15, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026